Pacira Pharmaceuticals reported $96.29M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 10.5M 37K
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Amerisourcebergen ABC:US $ 58350.53M 5565.56M
Astellas Pharma 4503:JP 271.44B 18.61B
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Coherus Biosciences CHRS:US $ 115.29M 3.48M
Depomed DEPO:US $ 19.54M 17.84M
Endo International Ordinary Shares ENDP:US $ 682.87M 112.15M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Horizon Pharma HZNP:US $ 705.45M 11.42M
Ironwood Pharmaceuticals IRWD:US $ 38.58M 0.36M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Lannett LCI:US $ 109.67M 30.16M
Ligand Pharmaceuticals LGND:US $ 49.23M 7.99M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Omeros OMER:US $ 48.26M 4.58M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Perrigo Ordinary Shares PRGO:US $ 604.4M 502.6M
Pfizer PFE:US $ 16447M 3384M
Revance Therapeutics RVNC:US $ 92.47M 3.33M
Supernus Pharmaceuticals SUPN:US $ 115.86M 8.64M
Teva Pharmaceutical TEVA:IT 3.26B 64M
Xeris Pharmaceuticals Inc XERS:US $ 35.42M 725K
Xoma XOMA:US $ 4.28M 20K
Zoetis ZTS:US $ 1.33B 19M